Literature DB >> 11757171

Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.

P W Roche1, K D Neupane, S S Failbus, A Kamath, W J Britton.   

Abstract

A DNA vaccine composed of the gene for the common mycobacterial secreted protein antigen 85B was demonstrated to protect the mouse foot pad against infection with Mycobacterium leprae. The protective effect was demonstrated by a 61%-88% reduction in the bacterial number, a protective effect less than that of BCG. The same DNA vaccine has been shown to protect mice against M. tuberculosis infection, and the importance of testing other candidate tuberculosis vaccines for their potential to protect against leprosy is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757171

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  6 in total

Review 1.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy.

Authors:  Helen D Donoghue; Antónia Marcsik; Carney Matheson; Kim Vernon; Emilia Nuorala; Joseph E Molto; Charles L Greenblatt; Mark Spigelman
Journal:  Proc Biol Sci       Date:  2005-02-22       Impact factor: 5.349

Review 3.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

4.  Pathogenesis and Host Immune Response in Leprosy.

Authors:  Hadida Yasmin; Praveen Mathews Varghese; Sanjib Bhakta; Uday Kishore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

Review 6.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.